what is microdosing glp 1 Why GLP-1 Microdosing? A Closer Look at Reported Benefits Microdosing GLP-1s: Risks & Considerations

A large study by Ohno and colleagues, published in Nature in 2020, found that the risk of developing RA rises with every roughly 5 kg of weight gain or every inch added to your waistline

Generally, an individual may be a candidate for GLP-1 therapy if: They have a Body Mass Index (BMI) of 30 or higher

*By clicking SUBMIT, you consent to receiving SMS messages

Specifically, robust and consistent protective effects were observed for schizophrenia and anxiety disorders, as evidenced by significant associations across all datasets analyzed

The research question was structured according to the Population, Intervention, Comparison, Outcomes, and Study design (PICOS) framework

I think this is an overblown concern